Trial Profile
A Prospective, Observational Study on the Use of Cetrotide (GnRH Antagonist) With GONAL-f in Assisted Reproductive Technologies (ART).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Cetrorelix (Primary) ; Follitropin alfa (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Sponsors Merck KGaA
- 23 Jan 2012 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 23 Jan 2012 Actual patient number is 2175 according to ClinicalTrials.gov.
- 23 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.